RecallDepth
Class II Ongoing

Norepinephrine Bitartrate in 5% Dextrose Injection, 8 mg/ 250 mL (32 mcg/mL), For Intravenous Infusion Only, 250 mL vial, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015. Made in Ireland. NDC: 0338-0108-20

This recall is currently active, issued February 28, 2024. It was issued by Baxter Healthcare Corporation.

Company
Baxter Healthcare Corporation
Recall Initiated
January 23, 2024
Posted
February 28, 2024
Recall Number
D-0336-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
13,000 bags
Firm Location
Deerfield, IL, United States
Official Source
View on FDA website ↗

Reason for Recall

Incorrect product concentration on the overwrap label: The overwrap label incorrectly identified the product strength as 4 mg / 250 mL; however, the primary bag label correctly identified the product strength as 8 mg / 250 mL.

Distribution

Nationwide in the USA

Lot / Code Info

Lot 23I21G64; Exp. 07/31/2024

More recalls by Baxter Healthcare Corporation

View all recalls by this company →

Other recent Class II Drug recalls